XML 30 R21.htm IDEA: XBRL DOCUMENT v3.22.2
Share-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Fair Value of Options
The fair value of the stock options granted is estimated on the date of grant using a Black-Scholes option pricing model with the following weighted-average assumptions:
 Three Months Ended June 30,Six Months Ended June 30,
 2022202120222021
Expected stock price volatility61.3 %65.5 %62.2 %66.4 %
Risk free interest rate3.0 %0.7 %1.6 %0.5 %
Expected life of options (years)5.35.45.35.4
Expected annual dividend per share$— $— $— $— 
Schedule of Stock Options Activity A summary of the Company's stock options for the six months ended June 30, 2022 were as follows:
Number of
Shares
Weighted Average Exercise 
Price
Weighted Average Remaining
Years
Aggregate
Intrinsic
Value
 (in thousands)  (in millions)
Options outstanding, December 31, 202114,731 $11.08   
Granted5,402 $11.55   
Exercised(339)$5.60   
Forfeited(333)$12.36   
Expired(178)$11.98 
Options outstanding, June 30, 202219,283 $11.28 7.0$22.2 
Vested and unvested expected to vest, June 30, 202217,589 $11.18 6.8$21.5 
Exercisable at June 30, 202210,377 $10.38 5.2$18.3 
Schedule of Non-Vested RSU Activity under the Plan A summary of non-vested RSU activity under the Plan for the six months ended June 30, 2022 is as follows:
Number of
Shares
Weighted
Average Grant
Date Fair
Value
Weighted 
Average
Remaining 
Years
Aggregate
Intrinsic
Value
(in thousands)(in millions)
Non-vested units as of December 31, 20217,341 $13.90   
Granted4,815 $11.97   
Vested(1,738)$12.40   
Forfeited(252)$12.10   
Non-vested units as of June 30, 202210,166 $13.13 2.4$109.2 
Schedule of Equity Compensation Expenses
The following table summarizes information related to compensation expense recognized in the Consolidated Statements of Operations related to the equity awards:
 Three Months Ended June 30,Six Months Ended June 30,
(in thousands)2022202120222021
Research and development expense$4,379 $3,152 $13,744 $9,457 
Selling, general, and administrative expense8,084 8,584 29,370 22,633 
Total equity compensation expense$12,463 $11,736 $43,114 $32,090